264 filings
Page 9 of 14
8-K
vpio4b3
30 Jul 20
Other Events
8:21am
8-K
smfe0r xd
27 Jul 20
Other Events
8:35am
8-K
of9ap5pa j3gnmxg
10 Jun 20
Submission of Matters to a Vote of Security Holders
5:03pm
UPLOAD
hxxh9m c2
27 May 20
Letter from SEC
12:00am
10-K/A
iocj bd9t
21 May 20
Annual report (amended)
4:15pm
CORRESP
qi5ob6icwc3vl2b2k
15 May 20
Correspondence with SEC
12:00am
8-K
fzziizo6qvcqmmixj2
14 May 20
Eton Pharmaceuticals Announces First Quarter 2020 Financial Results
4:09pm
8-K
ghjvhqr8u2v fg
7 May 20
Other Events
4:25pm
8-K
5951lxscpmrbm9lg
6 May 20
Entry into a Material Definitive Agreement
5:02pm
UPLOAD
d88nj i12u3d3c43xwg
5 May 20
Letter from SEC
12:00am
8-K
2o5w 80g4t13yw4dvv
4 May 20
Eton Pharmaceuticals Announces Appointment of Paul Stickler as Senior Vice President of Sales and Marketing
8:29am
DEFA14A
3que2uw 1dwbh
22 Apr 20
Additional proxy soliciting materials
5:04pm
D
h64dg1
8 Apr 20
$7.5M in equity, sold $7.5M, 2 investors
8:48am
SC 13G/A
8s55z jia3feh
7 Apr 20
Eton Pharmaceuticals / Opaleye Management ownership change
12:00am
3
a68cw23s ndst
6 Apr 20
Initial statement of insider ownership
7:16pm
424B5
okfdq2y4amixthx
30 Mar 20
Prospectus supplement for primary offering
8:39am
8-K
rwrpx4xe
30 Mar 20
Eton Pharmaceuticals Announces Acquisition of U.S Marketing Rights to Pediatric Orphan Drug AlkindiĀ® Sprinkle
8:32am